Monday, October 1, 2012

Takeda and Lundbeck Announce the U.S. Submission of a New Drug Application for Vortioxetine, an Investigational Drug for the Treatment of Major Depressive Disorder

...continued

URL: http://www.investorpoint.com/news/INTHPINK/54704305/

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)